Sarami I, Duffield AS, Sundaram S, Lin DI, Salib C, Hussein S, El Jamal S, Ghesani N, Cangut B, Petersen BE. An aggressive hematolymphoid neoplasm with homozygous SMARCB1 loss shows response to EZH2 inhibition. haematol [Internet]. 2025Nov.1 [cited 2026Apr.4];110(11):2849-54. Available from: https://haematologica.org/article/view/12133